ArticleBMC pregnancy and childbirth2026
Investigation of the effects of recombinant and urinary FSH used for ovulation induction on pregnancy results in an experimental animal model in terms of endometrial receptivity markers.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe aim of this study was to compare recombinant and urinary follicle stimulating hormone (FSH) with each other in terms of endometrial receptivity for the purpose of controlled ovarian stimulation.
methodsTwenty-four female albino mice (Mus musculus, C/C; 6-8 weeks, 18-22 g) and six males (8-10 weeks) were divided into four groups: control (no mating), spontaneous mating, urinary FSH (uFSH), and recombinant FSH (rFSH). Females in estrus received 5 IU of uFSH or rFSH, followed by mating after 48 h. Implantation sites were evaluated using histopathology and immunohistochemistry with anti-LIF, anti-Laminin, and integrin αVβ3 antibodies. LIF levels in serum collected from the tail vein were measured using ELISA.
resultsThe Tukey multiple comparison test showed significant group differences in Laminin and Integrin αVβ3 staining intensity (p < 0.001). rFSH treatment significantly increased Laminin and Integrin αVβ3 expression compared with both uFSH and spontaneous conception groups (p < 0.001), while uFSH also showed higher levels than the spontaneous group (p < 0.001). For LIF, no difference was found between the control and spontaneous groups (p > 0.05), but both rFSH and uFSH groups exhibited higher expression than the spontaneous group, with the highest levels in the rFSH group (p < 0.001).
conclusionrFSH treatment was associated with the greatest enhancement of endometrial receptivity markers, both immunohistochemically and biochemically, suggesting that rFSH may exert a more favorable effect on implantation potential compared with uFSH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.